Novel Prognostic Tool for ER+ Breast Cancer
Glucocorticoid Receptor promoter methylation has both positive and negative prognostic value for ER+ breast cancer patients
Published: 18th May 2021

IP Status
- Patented
Seeking
- Development partner
- Commercial partner
- Licensing
- Seeking investment